| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.303 | 13.948 | 16.352 | 15.589 | 20.781 |
| Total Income - EUR | - | - | - | - | - | 9.303 | 13.948 | 16.352 | 15.589 | 20.784 |
| Total Expenses - EUR | - | - | - | - | - | 6.446 | 6.782 | 11.420 | 15.693 | 12.434 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.857 | 7.166 | 4.932 | -104 | 8.351 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.593 | 6.798 | 4.451 | -1.024 | 6.794 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Provascular Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 54 | 0 | 84 | 4.390 | 1.366 |
| Current Assets | - | - | - | - | - | 4.757 | 11.425 | 4.681 | 4.961 | 9.439 |
| Inventories | - | - | - | - | - | 6 | 6 | 6 | 187 | 6 |
| Receivables | - | - | - | - | - | 2.067 | 1.011 | 2.699 | 2.350 | 2.631 |
| Cash | - | - | - | - | - | 2.683 | 10.409 | 1.975 | 2.424 | 6.803 |
| Shareholders Funds | - | - | - | - | - | 2.635 | 9.375 | 4.500 | 3.463 | 10.237 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.191 | 2.093 | 432 | 6.122 | 686 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Provascular Medical S.r.l.